U.K. Approves The Chimpanzee-Originated Oxford AstraZeneca’s COVID-19 Vaccine

Oxford Vaccine Group - Sponsored by Bill & Melinda Gates Foundation

AstraZeneca has been granted protection from future product liability claims related to its COVID-19 vaccine....

The Government has today accepted the recommendation from the Medicines and Healthcare Products Regulatory Agency (MHRA) to authorise Oxford University/AstraZeneca’s COVID-19 vaccine for use. This follows rigorous clinical trials and a thorough analysis of the data by experts at the MHRA, which has concluded that the vaccine has met its strict standards of safety, quality and effectiveness.

The vaccine doesn't have the coronavirus in it — instead, it's a type of chimpanzee-originated common cold that normally infects chimpanzees that can instruct human cells to make a coronavirus protein.

The solution is meant to help overcome the pre-existing immunity to a human adenovirus but it will also be the first time in the history of vaccines that an alien non-human chimpanzee virus will be used as a vector to produce a vaccine.

There are no long-term studies to demonstrate this technology’s safety.

There are also concerns related to known facts that many human diseases are caused by animal viruses.

The version of virus used in the AstraZeneca vaccine is found in Chimpanzees